ConductScience.org, home

Paper26344626

Therapeutic Vaccine Strategies against Human Papillomavirus.

Khallouf H and 2 others. Vaccines (Basel), 2014. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic Vaccine Strategies against Human Papillomavirus. Papers, record 26344626. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344626

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Vaccine Strategies against Human Papillomavirus.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2014
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.91
iCite
Revised in PubMed
2022-04-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Khallouf HHadeel
2Grabowska AKAgnieszka K
3Riemer ABAngelika B

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References210

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114975189Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity.Hum Gene Ther2004https://conductscience.org/library/papers/14975189PubMed
223557172HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.J Transl Med2013https://conductscience.org/library/papers/23557172PubMed
317473845More than one reason to rethink the use of peptides in vaccine design.Nat Rev Drug Discov2007https://conductscience.org/library/papers/17473845PubMed
410999722A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.Clin Cancer Res2000https://conductscience.org/library/papers/10999722PubMed
516288373Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.J Infect Dis2005https://conductscience.org/library/papers/16288373PubMed
621514130Viral vectors as vaccine platforms: deployment in sight.Curr Opin Immunol2011https://conductscience.org/library/papers/21514130PubMed
724485523Orchestrating immune check-point blockade for cancer immunotherapy in combinations.Curr Opin Immunol2014https://conductscience.org/library/papers/24485523PubMed
821029962Systems vaccinology.Immunity2010https://conductscience.org/library/papers/21029962PubMed
922700466Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.Int J Cancer2013https://conductscience.org/library/papers/22700466PubMed
1011342644Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene.J Immunol2001https://conductscience.org/library/papers/11342644PubMed
1121220591Human papillomaviruses as therapeutic targets in human cancer.J Clin Oncol2011https://conductscience.org/library/papers/21220591PubMed
1212559783Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.Vaccine2003https://conductscience.org/library/papers/12559783PubMed
1324007495Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.Hum Gene Ther2013https://conductscience.org/library/papers/24007495PubMed
1410746552Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.J Immunother2000https://conductscience.org/library/papers/10746552PubMed
1522051890Vaccines for the twenty-first century society.Nat Rev Immunol2011https://conductscience.org/library/papers/22051890PubMed
1621772284Solving vaccine mysteries: a systems biology perspective.Nat Immunol2011https://conductscience.org/library/papers/21772284PubMed
1715131030Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination.Clin Cancer Res2004https://conductscience.org/library/papers/15131030PubMed
1823994536Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.Gynecol Oncol2013https://conductscience.org/library/papers/23994536PubMed
1921748025Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.ISRN Obstet Gynecol2011https://conductscience.org/library/papers/21748025PubMed
2015665308Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency.Cancer Res2005https://conductscience.org/library/papers/15665308PubMed

See all 210 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
41901718The Exploration of Therapeutic Antivirals for Human Papillomavirus in the Last 40 Years: Bibliometric Research.Pathogens2026https://conductscience.org/library/papers/41901718PubMed
41667914Precision management of cervical cancer emphasizes immunotherapy combination regimens and translational advances.Discov Oncol2026https://conductscience.org/library/papers/41667914PubMed
41487403Molecular mechanisms of human papillomavirus-induced tongue carcinogenesis: A systematic review.J Oral Biol Craniofac Res2026https://conductscience.org/library/papers/41487403PubMed
40619783Human papillomavirus vaccine: Success and challenges.J Biosci2025https://conductscience.org/library/papers/40619783PubMed
40589751Immune responses to human papillomavirus infection and vaccination.Front Immunol2025https://conductscience.org/library/papers/40589751PubMed
40282913Evaluation of the Efficacy of Active Hexose Correlated Compound as an Adjuvant in Reducing Recurrence After Condyloma Cauterization.Medicina (Kaunas)2025https://conductscience.org/library/papers/40282913PubMed
39453911Design and antiviral assessment of a panel of fusion proteins targeting human papillomavirus type 16.PLoS One2024https://conductscience.org/library/papers/39453911PubMed
39339987Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study.Vaccines (Basel)2024https://conductscience.org/library/papers/39339987PubMed
39280196Primary Prevention in Cervical Cancer-Current Status and Way Forward.J Obstet Gynaecol India2024https://conductscience.org/library/papers/39280196PubMed
38983849Current status and future directions for the development of human papillomavirus vaccines.Front Immunol2024https://conductscience.org/library/papers/38983849PubMed
38605958Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.Front Immunol2024https://conductscience.org/library/papers/38605958PubMed
37600773Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies.Front Immunol2023https://conductscience.org/library/papers/37600773PubMed
36146843Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.Viruses2022https://conductscience.org/library/papers/36146843PubMed
34642315Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.Nat Commun2021https://conductscience.org/library/papers/34642315PubMed
33976146Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.Nat Commun2021https://conductscience.org/library/papers/33976146PubMed
32934952HSV-TK Expressing Mesenchymal Stem Cells Exert Inhibitory Effect on Cervical Cancer Model.Int J Mol Cell Med2020https://conductscience.org/library/papers/32934952PubMed
32922389Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations.Front Immunol2020https://conductscience.org/library/papers/32922389PubMed
32837456HPV16-E7 Protein T Cell Epitope Prediction and Global Therapeutic Peptide Vaccine Design Based on Human Leukocyte Antigen Frequency: An In-Silico Study.Int J Pept Res Ther2021https://conductscience.org/library/papers/32837456PubMed
32404527Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.J Virol2020https://conductscience.org/library/papers/32404527PubMed
31948126Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer.J Clin Med2020https://conductscience.org/library/papers/31948126PubMed

See all 37 cited byDownload CSV of cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
BAK1578PubTator's text mininghttps://conductscience.org/library/genes/578NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
HSP90B17184PubTator's text mininghttps://conductscience.org/library/genes/7184NCBI Gene
HSPA43308PubTator's text mininghttps://conductscience.org/library/genes/3308NCBI Gene
HSPD13329PubTator's text mininghttps://conductscience.org/library/genes/3329NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IRF33661PubTator's text mininghttps://conductscience.org/library/genes/3661NCBI Gene
LAMP13916PubTator's text mininghttps://conductscience.org/library/genes/3916NCBI Gene

See all 31 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26344626

GET https://conductscience.org/api/papers/v1/26344626/references?page=2